Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Genet ; 51(3): 231-8, 2008.
Article in English | MEDLINE | ID: mdl-18282818

ABSTRACT

We report on a fetus with multiple congenital anomalies including atypical lissencephaly, corpus callosum agenesis, cerebellar hypoplasia, cleft palate, ventricular septal defect, and hypoplastic aortic arch. The initial routine chromosome study failed to detect any abnormality. Subtelomeres analysis by MLPA identified an 18q23 duplication inherited from its healthy father. We describe the anomalies identified and discuss diagnosis and the causability of this telomeric duplication.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Aberrations , Chromosomes, Human, Pair 18 , Fetal Diseases/genetics , Humans , In Situ Hybridization, Fluorescence , Karyotyping , Nucleic Acid Hybridization
2.
Acta Neuropathol ; 114(4): 387-99, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17628812

ABSTRACT

We report three siblings, two of whom had a neuropathological study, with a new subtype of congenital ponto-cerebellar atrophy (PCH). In addition to the brain stem and cerebellar anomalies common to all types of this heterogeneous condition, there were unique developmental defects in the telencephalon: absence of the claustrum, diffuse cortical changes particularly in the insula and an extremely small brain. In an attempt to shed some light on the pathogenesis of this developmental disorder, we have analyzed the pattern of brain stem and cerebellar abnormalities in ours and in previously reported patients with PCH, to possibly distinguish primary from secondary effects of the mutant gene upon the cerebellar circuitry, and compared our patients' cerebellar and cerebral defects to those of some other human brain malformations and to mutant mice with both hindbrain and forebrain anomalies. Although this and previous observations of familial congenital PCH with apparent autosomal recessive inheritance spawn the endeavor to compare and classify patients into subgroups, any final classification must await identification and molecular characterization of the causal gene(s).


Subject(s)
Brain/abnormalities , Brain/pathology , Olivopontocerebellar Atrophies/pathology , Female , Humans , Infant, Newborn , Male , Pedigree , Pregnancy , Siblings
3.
J Comp Neurol ; 483(4): 375-82, 2005 Mar 21.
Article in English | MEDLINE | ID: mdl-15700272

ABSTRACT

Glial cells and extracellular matrix (ECM) molecules surround developing fiber tracts and are implicated in axonal pathfinding. These and other molecules are produced by these strategically located glial cells and have been shown to influence axonal growth across the midline in rodents. We searched for similar cellular and molecular structures surrounding the telencephalic commissures of fetal human brains. Paraffin-embedded brain sections were immunostained for glial fibrillary acidic protein (GFAP) and vimentin (VN) to identify glial cells; for microtubule-associated protein-2 (MAP-2) and neuronal nuclear protein (NeuN) to document neurons; for neurofilament (NF) to identify axons; and for chondroitin sulfate (CS), tenascin (TN), and fibronectin (FN) to show the ECM. As in rodents, three cellular clusters surrounding the corpus callosum were identified by their expression of GFAP and VN (but not MAP-2 or NeuN) from 13 to at least 18 weeks postovulation (wpo): the glial wedge, the glia of the indusium griseum, and the midline sling. CS and TN (but not FN) were expressed pericellularly in these cell groups. The anterior commissure was surrounded by a GFAP+/VN+ glial tunnel from 12 wpo, with TN expression seen between the GFAP+ cell bodies. The fimbria showed GFAP+/VN+ cells at its lateral and medial borders from 12 wpo, with pericellular expression of CS. The fornix showed GFAP+ cells somewhat later (16 wpo). Because these structures are similar to those described for rodents, we concluded that the axon guiding mechanisms postulated for commissural formation in nonhuman mammals may also be operant in the developing human brain.


Subject(s)
Corpus Callosum/cytology , Extracellular Matrix/metabolism , Prosencephalon/cytology , Axons/metabolism , Chondroitin Sulfates/metabolism , Corpus Callosum/embryology , Corpus Callosum/metabolism , Fetus , Fibronectins/metabolism , Glial Fibrillary Acidic Protein/metabolism , Humans , Immunohistochemistry/methods , Microtubule-Associated Proteins/metabolism , Neurofilament Proteins/metabolism , Neuroglia/metabolism , Neurons/metabolism , Phosphopyruvate Hydratase/metabolism , Prosencephalon/embryology , Prosencephalon/metabolism , Tenascin/metabolism , Vimentin/metabolism
4.
J Comp Neurol ; 476(3): 267-89, 2004 Aug 23.
Article in English | MEDLINE | ID: mdl-15269970

ABSTRACT

This study analyzed the expression of differentiation markers (Calbindin D28K: CaBP; parvalbumin: PARV; calretinin: CalR), gamma-aminobutyric acid (GABA) markers (GABA, glutamic acid decarboxylases: GAD65, GAD67; and GABA transporters: GAT1, GAT3), and other markers (neurotensin: NT, and neurofilament-specific protein: SMI32) in the human thalamus at 8-23 gestation weeks (g.w.), focusing on the motor-related nuclei. From 8-13 g.w. mainly CaBP was expressed in the cells while fiber bundles traversing the thalamus in addition to CaBP expressed all GABA markers except GAD67. CaBP and PARV expression patterns in different nuclei changed over the time course studied, whereas NT was expressed consistently along the anterior-lateral curvature of the thalamus. CalR and SMI were detectable at 23 g.w. in the ventral parts of the dorsal thalamus. Most remarkably, punctate GAD65 immunoreactivity in the neuropil was confined to the nigro- and pallidothalamic afferent receiving nuclei from 16 to about 21 g.w., overlapping with that of CaBP in some of these nuclei (subdivisions of the ventral anterior and mediodorsal nuclei) and with PARV in others (centromedian nucleus). During this period, GAD65 immunoreactivity can be considered a marker of the basal ganglia afferent receiving territory in the motor thalamus. GAD67-positive local circuit neurons were first detected at 12-13 g.w. in the thalamic nuclei outside the basal ganglia afferent receiving territory. In the ventral anterior and centromedian nuclei, GAD-containing local circuit neurons were not conspicuous even at 22-23 g.w. The cells of the reticular nucleus expressed GAD67 and PARV from 12 g.w. on starting in the lateral-posterior regions. By 23 g.w., both markers were expressed in about two-thirds of the nucleus except for its most medial-anterior part. The results imply spatially and temporally differential expression of GABA and differentiation markers in the developing human thalamus.


Subject(s)
Motor Neurons/cytology , Motor Neurons/metabolism , Thalamic Nuclei/embryology , Thalamic Nuclei/metabolism , gamma-Aminobutyric Acid/metabolism , Biomarkers/analysis , Calbindin 1 , Calbindin 2 , Calbindins , Cell Differentiation/physiology , Embryonic and Fetal Development , GABA Plasma Membrane Transport Proteins , Gene Expression Regulation, Developmental , Gestational Age , Glutamate Decarboxylase/genetics , Glutamate Decarboxylase/metabolism , Humans , Immunohistochemistry , Membrane Transport Proteins/metabolism , Neural Pathways/embryology , Neural Pathways/metabolism , Neurofilament Proteins/genetics , Neurofilament Proteins/metabolism , Neurotensin/genetics , Neurotensin/metabolism , Parvalbumins/genetics , Parvalbumins/metabolism , S100 Calcium Binding Protein G/genetics , S100 Calcium Binding Protein G/metabolism , Thalamic Nuclei/cytology , gamma-Aminobutyric Acid/genetics
5.
Exp Neurol ; 183(2): 499-507, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14552890

ABSTRACT

Synemin (Syn) is an intermediate filament (IF) protein. To gain insight into a morphogenetic role of Syn, we have studied its expression patterns in the developing human retina and lens and compared it with those of other IF proteins. In addition, we have tested Syn expression in fetuses (23 and 28 weeks) affected by Walker-Warburg syndrome (WWS), Meckel syndrome, and trisomy 13. In the retina, Syn expression starts in the nerve fiber and ganglion cell layers (NFL and GCL) at 15 weeks, remains there in up to 20 weeks, and spreads to other layers and may be colocalized with vimentin, GFA, or neurofilaments in the subsequent 16 weeks. This expansion of Synemin expression from 20 to 28 weeks is not observed in WWS in which Syn immunoreactivity in NFL is reduced and Vim expression is increased. Changes are seen in Syn or vimentin expressions in the retinae of 23-week-old Meckel syndrome or 28-week-old trisomy 13 fetuses. Syn expression in the lens is, at first (16 weeks), uniformly distributed, becoming stronger in the epithelium of the anterior part at 25 weeks and later. As in the retina, Syn expression in lens is also selectively affected in WWS. The colocalization of Synemin with vimentin, GFA, or NF supports the idea that Syn is a key cross-linking protein that connects different cytoskeletal structures. Moreover, stagnant Syn expression in WWS retina and lens reinforces the notion of a significant role of this protein in morphogenesis.


Subject(s)
Fetal Diseases/metabolism , Genetic Diseases, Inborn/metabolism , Lens, Crystalline/metabolism , Muscle Proteins/biosynthesis , Nervous System Malformations/metabolism , Retina/metabolism , Fetal Diseases/pathology , Genetic Diseases, Inborn/pathology , Glial Fibrillary Acidic Protein/biosynthesis , Humans , Immunohistochemistry , Intermediate Filament Proteins , Lens, Crystalline/abnormalities , Lens, Crystalline/pathology , Nervous System Malformations/pathology , Neurofilament Proteins/biosynthesis , Reference Values , Retina/abnormalities , Retina/pathology , Syndrome , Trisomy/pathology , Vimentin/biosynthesis
6.
J Neurobiol ; 55(3): 288-98, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12717699

ABSTRACT

In the human brain, the transformation of radial glial cells (RGC) into astrocytes has been studied only rarely. In this work, we were interested in studying the morphologic aspects underlying this transformation during the fetal/perinatal period, particularly emphasizing the region-specific glial fiber anatomy in the medial cortex. We have used carbocyanine dyes (DiI/DiA) to identify the RGC transitional forms and glial fiber morphology. Immunocytochemical markers such as vimentin and glial fibrillary acidic protein (GFAP) were also employed to label the radial cells of glial lineage and to reveal the early pattern of astrocyte distribution. Neuronal markers such as neuronal-specific nuclear protein (NeuN) and microtubule-associated protein (MAP-2) were employed to discern whether or not these radial cells could, in fact, be neurons or neuronal precursors. The main findings concern the beginning of RGC transformation showing loss of the ventricular fixation in most cases, followed by transitional figures and the appearance of mature astrocytes. In addition, diverse fiber morphology related to depth within the cortical mantle was clearly demonstrated. We concluded that during the fetal/perinatal period the cerebral cortex is undergoing the final stages of radial neuronal migration, followed by involution of RGC ventricular processes and transformation into astrocytes. None of the transitional or other radial glia were positive for neuronal markers. Furthermore, the differential morphology of RGC fibers according to depth suggests that factors may act locally in the subplate and could have a role in the process of cortical RGC transformation and astrocyte localization. The early pattern of astrocyte distribution is bilaminar, sparing the cortical plate. Few astrocytes (GFAP+) in the upper band could be found with radial processes at anytime. This suggests that astrocytes in the marginal zone could be derived from different precursors than those that differentiate from RGCs during this period.


Subject(s)
Astrocytes/cytology , Cell Differentiation/physiology , Cerebral Cortex/growth & development , Neuroglia/cytology , Stem Cells/cytology , Astrocytes/metabolism , Cerebral Cortex/cytology , Embryo, Mammalian , Female , Fetus , Glial Fibrillary Acidic Protein/metabolism , Humans , Immunohistochemistry , Infant, Newborn , Microtubule-Associated Proteins/metabolism , Munc18 Proteins , Nerve Tissue Proteins/metabolism , Neuroglia/metabolism , Pregnancy , Vesicular Transport Proteins/metabolism , Vimentin/metabolism
7.
Cardiol Young ; 12(3): 278-83, 2002 May.
Article in English | MEDLINE | ID: mdl-12365176

ABSTRACT

Isolated non-compaction of the ventricular myocardium is characterized by numerous and prominent trabeculations and deep intertrabecular recesses. This rare disease is due to an arrest of myocardial morphogenesis. Most cases, when seen in children, are associated with obstructive malformations. Isolated non-compaction is even rarer in childhood, and affects predominantly the myocardium of the left ventricle. Morbidity and mortality resulting from cardiovascular complications is high. In most cases, transplantation is the final option. To our knowledge, this rare cardiac malformation has yet to be diagnosed in the fetus. We report here two sporadic cases, one male and one female, and 2 familial cases, both male, which were diagnosed prenatally and followed by fetal echocardiography. Our study indicates that isolated non-compaction is a primary disorder of early fetal development. Our cross-sectional echocardiographic examinations revealed a fetal cardiomyopathy, with prominent and numerous trabeculations and deep intertrabecular recesses of the myocardium at the apex of the ventricles. In contrast with postnatal experience, we found isolated non-compaction mostly in the right ventricle. Systolic dysfunction was found in all cases. The diagnosis was confirmed by histology in 3 fetuses dying with cardiac failure, and by postnatal cross-sectional echocardiography in the fetus who survived. Two male fetuses belonged to a family in which 3 individuals were subsequently found to be affected. We discuss the issues of prenatal diagnosis, natural history, and myocardial histology.


Subject(s)
Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/embryology , Heart/embryology , Myocardium/pathology , Ultrasonography, Prenatal , Adolescent , Adult , Echocardiography , Female , Gestational Age , Heart Defects, Congenital/genetics , Heart Ventricles/abnormalities , Heart Ventricles/diagnostic imaging , Heart Ventricles/embryology , Humans , Male , Pedigree , Pregnancy , Pregnancy Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...